Key result
Short daily haemodialysis improved several dimensions of health-related quality of life but had no clear effects on cognitive functioning and EEG compared to conventional haemodialysis.
Why the study?
Does short daily haemodialysis improve quality of life, cognitive functioning, and EEG in end-stage renal disease patients compared to conventional haemodialysis?
Cohort (n=22)
Does short daily haemodialysis improve quality of life, cognitive functioning, and EEG in end-stage renal disease patients compared to conventional haemodialysis?
Short daily haemodialysis improves health-related quality of life in end-stage renal disease patients but does not significantly affect cognitive functioning or EEG.
Answers are grounded in this paper and cite their sources.
Short daily haemodialysis was associated with better quality of life in ESRD; leaves open effects on cognition and EEG, warranting RCTs.
BACKGROUND: End-stage renal disease patients have a poor quality of life (QoL), suffer from impaired cognitive functioning, and their electroencephalogram (EEG) shows abnormalities. Conventional haemodialysis (CHD) only partially restores these disorders. Short daily haemodialysis (SDHD) has been reported to improve QoL, but effects on cognitive functioning and EEG have yet to be described. METHODS: Of the 13 patients (11 male, 2 female, age 45.5 +/- 8.1 years), 11 completed the Kidney Disease Quality of Life and Affect Balance Scale questionnaires, 10 underwent neuropsychological testing, and all 13 underwent EEG examination. For the neuropsychological assessments, nine patients (six male, three female, age 45.4 +/- 12.6) who remained on the CHD schedule, served as controls. The dialysis schedule of thrice-a-week for 4 h was changed in the experimental group to six times a week for 2 h (SDHD) over a period of 6 months and back to thrice a week for 4 h. RESULTS: When on SDHD, patients rated several dimensions of health-related QoL as being improved. After resuming CHD, one of these dimensions again decreased and several others worsened even lower than baseline. Cognitive functioning did not change when compared with control data. On the EEG, alpha peak frequency increased slightly when on SDHD but decreased significantly after resuming CHD. CONCLUSIONS: SDHD improves health-related QoL, but has no clear effects on cognitive functioning and EEG. Resumption of CHD after SDHD decreases aspects of QoL and EEG alpha peak frequency but has no effect on cognitive functioning.
No takes yet. Share an insight, caveat, or question.
Vos et al. (2006) conducted a cohort in End-stage renal disease (n=22). Short daily haemodialysis (SDHD) vs. Conventional haemodialysis (thrice a week for 4 hours) was evaluated on Quality of life, cognitive functioning, and electroencephalogram (EEG) abnormalities. Short daily haemodialysis improved several dimensions of health-related quality of life but had no clear effects on cognitive functioning and EEG compared to conventional haemodialysis.
Synapse has enriched 10 related papers. Consider them for comparative context: